Understanding supplements.
How do I evaluate what you're actually buying — in the aisle that sells 'nerve health' with the vitamin that harms it?
The nervous system aisle is the estate's most ironic shelf: its flagship category — the 'nerve health complex' — routinely contains 100 mg+ of vitamin B6, the exact chronic dose documented to CAUSE the sensory neuropathy the label promises to prevent. Around that trap sit the gray-market nootropics (unverified powders borrowing trial claims from other molecules), the 'brain boosters' with no outcomes data, and — the honest minority — a guideline-badged mineral, an indication-trialed antioxidant, and the membrane fat with its formulation lesson. Evaluation here is label arithmetic (the B6 line first), formulation literacy (EPA vs. DHA, glycinate vs. oxide, standardized vs. bulk), and the border-keeping that says: the nervous system's emergencies are minutes-tier and its diseases are prescription-tier; the shelf's honest job is the margin.
Magnesium Glycinate
Elemental-counted, evening-timed
ALA 600 mg Capsules
The trial dose, empty stomach
EPA-Forward Softgels
The ratio matched to the claim
'Nerve Health Complexes'
The B6-megadose trap
Glycinate ✅
~40% absorbed, GI-gentle — the form that lets migraine-relevant and excitability-relevant doses run without the laxative cost. Count ELEMENTAL mg per capsule toward the 350 mg ceiling (our magnesium page's label rule). Evening timing pairs the gate's quieting with the wind-down window.
Oxide — Avoid
~4% absorbed, mostly a laxative — the cheap form that gives the mineral its GI reputation (our magnesium page's Chapter 1). For a system whose complaint is often anxiety-adjacent, the oxide's GI side effects are a false signal of 'intolerance' to a mineral the body may need.
Choosing the Right Form & Dose
Label literacy in the nervous system aisle has four specific jobs:
- The B6 line, first, always: any 'nerve,' 'stress,' or 'brain' formula — find the B6 dose. Under 25 mg: reasonable. 100 mg+ (the common megadose): the inversion trap — put the bottle down. The one reading that outranks every other on this shelf.
- Elemental magnesium math: 200 mg elemental per capsule, glycinate form, counted toward the 350 mg ceiling — the migraine-prevention trials used 300–600 mg elemental daily.
- ALA at the trial pattern: 600 mg, empty stomach, 2+ hours from minerals — the German program's dose and timing.
- EPA-dose matching for mood: the adjunct trials used ~1 g+ EPA; read the EPA line and either match the dose or size the expectations down to the serving.
- The standing rule: third-party verification (USP, NSF, ConsumerLab, IFOS) — in the category where gray-market powders and megadose complexes are routine, the verified label is the floor, not the ceiling, of the evaluation.
Red Flags to Watch For
The nervous system market sells to the frightened and the fogged. Be highly cautious of products that:
- Contain 100 mg+ B6 in a 'nerve health complex' — the documented inversion: the cofactor causing the neuropathy it's sold to prevent. The clearest single red flag in the estate.
- Sell 'nootropic' blends and racetam-class powders — gray-market molecules with borrowed claims, unverified contents, and no nervous-system safety file: the cognitive aisle's unregulated edge.
- Promise to 'heal nerves' or 'regenerate the nervous system' — established axonal damage does not regenerate on any shelf; the claim itself is the disqualification (the honest adjuncts say 'symptom relief,' and mean it).
- Market 'brain boosters' on college campuses — the productivity demographic sold stimulation stacks with anxiety and sleep costs (our anxiety page's caffeine notes, bundled and branded).
- Lack third-party verification — in the category with the gray-market's worst label-accuracy record, the unverified label is the unassessed dose.